Dabur India Ltd vs Nath Bio Genes India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 24, 2026

Key Highlights

The Latest Trading Price of Dabur India Ltd is ₹ 385.15 as of 24 Sep 16:01 . The P/E Ratio of Dabur India Ltd changed from 56.4 on March 2021 to 38.4 on March 2026 . This represents a CAGR of -6.21% over 6 yearsThe P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 years The Market Cap of Dabur India Ltd changed from ₹ 95564 crore on March 2021 to ₹ 72792 crore on March 2026 . This represents a CAGR of -4.44% over 6 yearsThe Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 years The revenue of Dabur India Ltd for the Jun '26 is ₹ 3936 crore as compare to the Mar '26 revenue of ₹ 3213 crore. This represent the growth of 22.53% The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The ebitda of Dabur India Ltd for the Jun '26 is ₹ 913.45 crore as compare to the Mar '26 ebitda of ₹ 635.85 crore. This represent the growth of 43.66% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The net profit of Dabur India Ltd changed from ₹ 494.35 crore to ₹ 586.16 crore over 9 quarters. This represents a CAGR of 7.87% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The Dividend Payout of Dabur India Ltd changed from 60.75 % on March 2021 to 98.13 % on March 2026 . This represents a CAGR of 8.32% over 6 yearsThe Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Dabur India Ltd

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products.
The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods.
Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products. The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD).
Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods.

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

FAQs for the comparison of Dabur India Ltd and Nath Bio-Genes (India) Ltd

Which company has a larger market capitalization, Dabur India Ltd or Nath Bio-Genes (India) Ltd?

Market cap of Dabur India Ltd is 68,829 Cr while Market cap of Nath Bio-Genes (India) Ltd is 280 Cr

What are the key factors driving the stock performance of Dabur India Ltd and Nath Bio-Genes (India) Ltd?

The stock performance of Dabur India Ltd and Nath Bio-Genes (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dabur India Ltd and Nath Bio-Genes (India) Ltd?

As of September 24, 2026, the Dabur India Ltd stock price is INR ₹388.0. On the other hand, Nath Bio-Genes (India) Ltd stock price is INR ₹147.35.

How do dividend payouts of Dabur India Ltd and Nath Bio-Genes (India) Ltd compare?

To compare the dividend payouts of Dabur India Ltd and Nath Bio-Genes (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.